Skip to main content
ETON
NASDAQ Life Sciences

Officer Files Intent to Sell $3.5M in Eton Pharmaceuticals Stock

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$32.59
Mkt Cap
$892.717M
52W Low
$13.085
52W High
$35.66
52W Position info
149% above low
Off High info
8.6% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

ETON has more than doubled off its 52-week low of $13.085.

Summary

An officer at Eton Pharmaceuticals has filed a Form 144 to sell 100,000 shares worth $3.5 million, following a period of strong company performance and stock appreciation.


Key Events · Ownership and Investor Activity · ETON

  • Officer Files Intent to Sell Shares

    David Krempa, an officer of Eton Pharmaceuticals, has filed a Form 144 indicating an intent to sell 100,000 common shares.

  • Significant Proposed Sale Value

    The proposed sale has an approximate market value of $3.5 million.

  • Follows Strong Company Performance

    This intent to sell comes after a period of positive company news, including FDA approvals, strong Q1 2026 financial results, and a recent stock surge.


Analysis · ETON · Life Sciences

An officer of Eton Pharmaceuticals, David Krempa, has filed a Form 144 indicating an intent to sell 100,000 shares, valued at approximately $3.5 million. This filing follows a period of significant positive news for the company, including FDA approvals, strong financial results, and a recent stock surge. While this is an intent to sell and not an actual transaction, the proposed sale by an officer can be perceived as profit-taking after recent gains and may create some selling pressure.

How filings like this one have moved

In the 30 days to Nov 9, 2026, 36.6% of the 2965 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ETON was trading at $32.59 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $892.7M. The 52-week trading range was $13.09 to $35.66. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ETON - Latest Insights

ETON
Nov 06, 2026, 9:04 AM EST
Source: Seeking Alpha
Importance Score:
8
Price at Filing: $58.86
Real-time Price: $56.80 info
Change: -$2.06 (-3%) info
Market Cap: $1.614B info
ETON
Nov 05, 2026, 4:32 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $57.90
Real-time Price: $56.80 info
Change: -$1.10 (-2%) info
Market Cap: $1.614B info
ETON
Nov 05, 2026, 4:13 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $56.06
Real-time Price: $56.80 info
Change: +$0.7355 (+1%) info
Market Cap: $1.614B info
ETON
Nov 05, 2026, 4:05 PM EST
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $47.15
Real-time Price: $56.80 info
Change: +$9.65 (+20%) info
Market Cap: $1.614B info
ETON
Nov 05, 2026, 4:03 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $47.15
Real-time Price: $56.80 info
Change: +$9.65 (+20%) info
Market Cap: $1.614B info